Evidence based venous thromboprophylaxis in patients undergoing total hip replacement (THR), total knee replacement (TKR) and hip fracture surgery (HFS)

被引:1
|
作者
Autar, Ricky [1 ]
机构
[1] De Montfort Univ, Fac Hlth & Life Sci, Charles Frears Campus,266 London Rd, Leicester LE2 1RQ, Leics, England
关键词
Venous thromboembolism; Venous thromboprophylaxis; Deep vein thrombosis; Pulmonary embolism; Total hip replacement; Total knee replacement; Hip fracture surgery; Mechanical prophylaxis; Pharmacological prophylaxis; Venous thromboprophylaxis guidelines;
D O I
10.1016/j.ijotn.2011.01.001
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Patients undergoing total hip, knee replacement and hip fracture surgery are at high risk of developing venous thromboembolism. Incidence of deep vein thrombosis ranges from 40% to 70% and 1% to 7% for fatal pulmonary embolism. Venous thromboprophylaxis comprises mechanical and pharmacological intervention but for added protection in major orthopaedic surgery, most national and international guidelines advise a combined regimen of both modalities. Reportedly, 40% of such patients do not receive pharmacological prophylaxis because of the increased risk of bleeding. When considering pharmacological prophylaxis, a trade off between the benefits of reducing venous thromboembolism and the potential harms of bleeding and haematoma formation must be balanced. Anti-embolism stockings, intermittent pneumatic pump and foot impulse devices are the main mechanical methods but are often collectively addressed as mechanical prophylaxis as no difference in efficacy exists between these devices. The National Institute for Health and Clinical Excellence advises that one of those devices be commenced preoperatively and continued until the patients have no significant reduced immobility. Anti-embolism stockings (knee or thigh) are to be applied with caution. Mechanical prophylaxis is particularly important in hip/knee and hip fracture surgery, when patients are not protected by pharmacological prophylaxis. Unfractionated heparin, low molecular weight heparin, pentasaccharide fondaparinux and old and new oral anticoagulants are the mainstay of pharmacological prophylaxis. In the absence of contraindication, it is recommended that pharma-cological prophylaxis is timely initiated postoperatively. Extended pharmacological prophylaxis is recommended for 28-35 days for hip replacement and hip fracture surgery and 10-14 days for knee replacement surgery. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:145 / 154
页数:10
相关论文
共 50 条
  • [21] NEW ANTICOAGULANTS AS THROMBOPROPHYLAXIS AFTER TOTAL HIP OR KNEE REPLACEMENT
    Hamidi, Vida
    Ringerike, Tove
    Hagen, Gunhild
    Reikvam, Asmund
    Klemp, Marianne
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2013, 29 (03) : 234 - 243
  • [22] Cost-effectiveness of rivaroxaban for prevention of venous thromboembolism (VTE) after total hip or knee replacement (THR, TKR) in the USA
    Kwong, L.
    Duran, A.
    Diamantopoulos, A.
    Sengupta, N.
    Lees, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 787 - 787
  • [23] Readability of Information on Smartphone Apps for Total Hip Replacement and Total Knee Replacement Surgery Patients
    Bahadori, Shayan
    Wainwright, Thomas W.
    Ahmed, Osman H.
    JOURNAL OF PATIENT EXPERIENCE, 2020, 7 (03): : 395 - 398
  • [24] Smartphone apps for total hip replacement and total knee replacement surgery patients: a systematic review
    Bahadori, Shayan
    Wainwright, Thomas W.
    Ahmed, Osman H.
    DISABILITY AND REHABILITATION, 2020, 42 (07) : 983 - 988
  • [25] Performance of New Anticoagulants for Thromboprophylaxis in Patients Undergoing Hip and Knee Replacement Surgery
    Mahan, Charles E.
    Kaatz, Scott
    PHARMACOTHERAPY, 2012, 32 (11): : 1036 - 1048
  • [26] Hip Fracture Surgery vs Elective Total Hip Replacement
    Metcalfe, David
    Perry, Daniel C.
    Costa, Matthew L.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (09): : 941 - 942
  • [27] Prevention of Venous Thromboembolism in Total Knee and Hip Replacement
    Warwick, David
    CIRCULATION, 2012, 125 (17) : 2151 - 2155
  • [28] Population Pharmacokinetics of Periarticular Ketorolac in Adult Patients Undergoing Total Hip or Total Knee Replacement Surgery
    Gurunathan, Usha
    Parker, Suzanne L.
    Maguire, Richard
    Ramdath, Dale
    Bijoor, Manu
    Wallis, Steven C.
    Roberts, Jason A.
    ANESTHESIA AND ANALGESIA, 2019, 129 (03): : 701 - 708
  • [29] TEACHING OF PATIENTS UNDERGOING TOTAL HIP-REPLACEMENT SURGERY
    SANTAVIRTA, N
    LILLQVIST, G
    SARVIMAKI, A
    HONKANEN, V
    KONTTINEN, YT
    SANTAVIRTA, S
    INTERNATIONAL JOURNAL OF NURSING STUDIES, 1994, 31 (02) : 135 - 142
  • [30] Rehabilitation Following Total Knee Replacement, Total Hip Replacement, and Hip Fracture: A Case-Controlled Comparison
    Herbold, Janet A.
    Bonistall, Kristen
    Walsh, Mary Beth
    JOURNAL OF GERIATRIC PHYSICAL THERAPY, 2011, 34 (04) : 155 - 160